Co-Diagnostics, Inc. Income Tax Expense
Co-Diagnostics, Inc. (CODX) reported Income Tax Expense of $19.17 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-13
- Co-Diagnostics, Inc. income tax expense (benefit) for the quarter ending 2026-06-30 was $19.17K, a 55.50% increase year-over-year.
- Co-Diagnostics, Inc. income tax expense (benefit) for the quarter ending 2026-03-31 was $520.00, a 95.67% decline year-over-year.
- Co-Diagnostics, Inc. income tax expense (benefit) for the quarter ending 2025-12-31 was -$473.72K.
- Co-Diagnostics, Inc. income tax expense (benefit) for the quarter ending 2025-09-30 was -$1.17M, a 5357.53% decline year-over-year.
- Co-Diagnostics, Inc. income tax expense (benefit) for fiscal 2025 was -$1.62M, a 2916.86% decline from fiscal 2024.
- Co-Diagnostics, Inc. income tax expense (benefit) for fiscal 2024 was $57.37K.
- Co-Diagnostics, Inc. income tax expense (benefit) for fiscal 2023 was -$2.78M.
- Co-Diagnostics, Inc. income tax expense (benefit) for fiscal 2022 was -$4.61M, a 151.34% decline from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.17K 10-Q · filed 2026-08-13 | $19.69K 10-Q · filed 2026-08-13 | -$454.03K derived: sum of 3 quarters · filed 2026-08-13 | -$1.62M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $520.00 10-Q · filed 2026-05-14 | -$473.20K derived: sum of 2 quarters · filed 2026-05-14 | -$1.64M derived: sum of 3 quarters · filed 2026-05-14 | -$1.63M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$473.72K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$1.64M derived: sum of 2 quarters · filed 2026-03-31 | -$1.63M derived: sum of 3 quarters · filed 2026-08-13 | -$1.62M 10-K · filed 2026-03-31 |
| 2025-09-30 | -$1.17M 10-Q · filed 2025-11-13 | -$1.15M derived: sum of 2 quarters · filed 2026-08-13 | -$1.14M 10-Q · filed 2025-11-13 | -$1.15M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $12.33K 10-Q · filed 2026-08-13 | $24.33K 10-Q · filed 2026-08-13 | $16.16K derived: sum of 3 quarters · filed 2026-08-13 | $38.34K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $12.00K 10-Q · filed 2026-05-14 | $3.83K derived: sum of 2 quarters · filed 2026-05-14 | $26.02K derived: sum of 3 quarters · filed 2026-05-14 | $46.61K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$8.18K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $14.01K derived: sum of 2 quarters · filed 2026-03-31 | $34.60K derived: sum of 3 quarters · filed 2026-03-31 | $57.37K 10-K · filed 2026-03-31 |
| 2024-09-30 | $22.19K 10-Q · filed 2025-11-13 | $42.78K derived: sum of 2 quarters · filed 2025-11-13 | $65.54K 10-Q · filed 2025-11-13 | $3.90M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $20.59K 10-Q · filed 2025-08-14 | $43.35K 10-Q · filed 2025-08-14 | $3.88M derived: sum of 3 quarters · filed 2025-08-14 | $1.76M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $22.76K 10-Q · filed 2025-05-08 | $3.86M derived: sum of 2 quarters · filed 2025-05-08 | $1.74M derived: sum of 3 quarters · filed 2025-05-08 | -$495.12K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $3.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $1.72M derived: sum of 2 quarters · filed 2025-03-27 | -$517.88K derived: sum of 3 quarters · filed 2025-03-27 | -$2.78M 10-K · filed 2025-03-27 |
| 2023-09-30 | -$2.11M 10-Q · filed 2024-11-07 | -$4.35M derived: sum of 2 quarters · filed 2024-11-07 | -$6.61M 10-Q · filed 2024-11-07 | -$9.75M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$2.24M 10-Q · filed 2024-08-08 | -$4.50M 10-Q · filed 2024-08-08 | -$7.64M derived: sum of 3 quarters · filed 2024-08-08 | -$9.75M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$2.26M 10-Q · filed 2024-05-09 | -$5.40M derived: sum of 2 quarters · filed 2024-05-09 | -$7.51M derived: sum of 3 quarters · filed 2024-05-09 | -$8.25M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$5.25M derived: sum of 2 quarters · filed 2024-03-14 | -$6.00M derived: sum of 3 quarters · filed 2024-03-14 | -$4.61M 10-K · filed 2024-03-14 |
| 2022-09-30 | -$2.11M 10-Q · filed 2023-11-09 | -$2.86M derived: sum of 2 quarters · filed 2023-11-09 | -$1.47M 10-Q · filed 2023-11-09 | $1.28M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$741.51K 10-Q · filed 2023-08-10 | $644.58K 10-Q · filed 2023-08-10 | $3.39M derived: sum of 3 quarters · filed 2023-08-10 | $5.49M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $1.39M 10-Q · filed 2023-05-11 | $4.13M derived: sum of 2 quarters · filed 2023-05-11 | $6.23M derived: sum of 3 quarters · filed 2023-05-11 | $8.38M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $4.85M derived: sum of 2 quarters · filed 2023-03-16 | $6.99M derived: sum of 3 quarters · filed 2023-03-16 | $8.98M 10-K · filed 2023-03-16 |
| 2021-09-30 | $2.10M 10-Q · filed 2022-11-10 | $4.25M derived: sum of 2 quarters · filed 2022-11-10 | $6.23M 10-Q · filed 2022-11-10 | $9.24M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $2.15M 10-Q · filed 2022-08-11 | $4.13M 10-Q · filed 2022-08-11 | $7.14M derived: sum of 3 quarters · filed 2022-08-11 | $4.22M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $1.99M 10-Q · filed 2022-05-12 | $4.99M derived: sum of 2 quarters · filed 2022-05-12 | $2.08M derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $90.54K derived: sum of 2 quarters · filed 2022-03-24 | $90.54K 10-K · filed 2022-03-24 | |
| 2020-09-30 | -$2.91M 10-Q · filed 2021-11-12 | -$2.91M 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |